Russell C. Callaghan
Russell C. Callaghan
Northern Medical Program, University of Northern British Columbia
Verified email at unbc.ca
Title
Cited by
Cited by
Year
Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs
RC Callaghan, JK Cunningham, J Sykes, SJ Kish
Drug and alcohol dependence 120 (1-3), 35-40, 2012
2342012
Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression
RC Callaghan, S Veldhuizen, T Jeysingh, C Orlan, C Graham, G Kakouris, ...
Journal of psychiatric research 48 (1), 102-110, 2014
2142014
Marijuana use and risk of lung cancer: a 40-year cohort study
RC Callaghan, P Allebeck, A Sidorchuk
Cancer Causes & Control 24 (10), 1811-1820, 2013
1912013
Does stage-of-change predict dropout in a culturally diverse sample of adolescents admitted to inpatient substance-abuse treatment? A test of the Transtheoretical Model
RC Callaghan, A Hathaway, JA Cunningham, LC Vettese, S Wyatt, ...
Addictive behaviors 30 (9), 1834-1847, 2005
1542005
Incidence of Parkinson's disease among hospital patients with methamphetamine‐use disorders
RC Callaghan, JK Cunningham, G Sajeev, SJ Kish
Movement Disorders 25 (14), 2333-2339, 2010
1352010
Methamphetamine use and schizophrenia: a population-based cohort study in California
RC Callaghan, JK Cunningham, P Allebeck, T Arenovich, G Sajeev, ...
American Journal of Psychiatry 169 (4), 389-396, 2012
1342012
Gender differences in detoxification: predictors of completion and re-admission
RC Callaghan, JA Cunningham
Journal of substance abuse treatment 23 (4), 399-407, 2002
1012002
Prevalence of unassisted quit attempts in population-based studies: a systematic review of the literature
SA Edwards, SJ Bondy, RC Callaghan, RE Mann
Addictive behaviors 39 (3), 512-519, 2014
642014
The incidence of cardiovascular morbidity among patients with bipolar disorder: a population-based longitudinal study in Ontario, Canada
RC Callaghan, A Khizar
Journal of affective disorders 122 (1-2), 118-123, 2010
562010
Impact of US and Canadian precursor regulation on methamphetamine purity in the United States
JK Cunningham, LM Liu, R Callaghan
Addiction 104 (3), 441-453, 2009
552009
Alcohol-or drug-use disorders and motor vehicle accident mortality: A retrospective cohort study
RC Callaghan, JM Gatley, S Veldhuizen, S Lev-Ran, R Mann, M Asbridge
Accident Analysis & Prevention 53, 149-155, 2013
522013
Brain dopamine neurone ‘damage’: methamphetamine users vs. Parkinson's disease–a critical assessment of the evidence
SJ Kish, I Boileau, RC Callaghan, J Tong
European Journal of Neuroscience 45 (1), 58-66, 2017
472017
Risk factors associated with dropout and readmission among First Nations individuals admitted to an inpatient alcohol and drug detoxification program
RC Callaghan
Cmaj 169 (1), 23-27, 2003
472003
Estimating the harms and costs of cannabis-attributable collisions in the Canadian provinces
A Wettlaufer, RO Florica, M Asbridge, D Beirness, J Brubacher, ...
Drug and alcohol dependence 173, 185-190, 2017
462017
Alcohol use disorders and risk of Parkinson’s disease: findings from a Swedish national cohort study 1972–2008
AK Eriksson, S Löfving, RC Callaghan, P Allebeck
BMC neurology 13 (1), 1-6, 2013
452013
All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study
RC Callaghan, JK Cunningham, M Verdichevski, J Sykes, SR Jaffer, ...
Drug and alcohol dependence 125 (3), 290-294, 2012
432012
Does progressive stage transition mean getting better? A test of the Transtheoretical Model in alcoholism recovery
RC Callaghan, L Taylor, JA Cunningham
Addiction 102 (10), 1588-1596, 2007
422007
Cannabis use and incidence of testicular cancer: a 42-year follow-up of Swedish men between 1970 and 2011
RC Callaghan, P Allebeck, O Akre, KA McGlynn, A Sidorchuk
Cancer Epidemiology and Prevention Biomarkers 26 (11), 1644-1652, 2017
392017
Schizophrenia and the incidence of cardiovascular morbidity: a population-based longitudinal study in Ontario, Canada
RC Callaghan, MD Boire, RG Lazo, K McKenzie, T Cohn
Schizophrenia research 115 (2-3), 325-332, 2009
392009
Recovery and URICA stage-of-change scores in three marijuana treatment studies
RC Callaghan, L Taylor, BA Moore, FS Jungerman, FADB Vilela, ...
Journal of Substance Abuse Treatment 35 (4), 419-426, 2008
382008
The system can't perform the operation now. Try again later.
Articles 1–20